Significant Ownership of Orin Hirschman
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Orin Hirschman focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Orin Hirschman - Orin Hirschman
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Orin Hirschman and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Orin Hirschman
Significant Ownership of Orin Hirschman
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NYXH | NYXOAH SA | Common Stock | 14% | $43,459,291 | 14,534,880 | Orin Hirschman | 10 Jun 2026 | ||
| CGEH | Capstone Green Energy Corporation | Common Stock, $0.001 par value per share | 9.9% | $11,508,528 | 2,280,000 | Orin Hirschman | 31 Dec 2025 | ||
| WATT | ENERGOUS CORPORATION | Common Stock, $0.00001 par value | 9.9% | $9,114,945 | 580,825 | Orin Hirschman | 31 Mar 2026 | ||
| SMTK | SmartKem, Inc. | Common Stock | 9.9% | $983,825 | +$457,788 | 678,500 | +87% | Orin Hirschman | 31 Dec 2025 |
| APRE | Aprea Therapeutics, Inc. | Common Stock, $0.001 par value per share | 9.9% | 1,186,294 | +82% | Orin Hirschman | 31 Mar 2026 | ||
| DROR | Dror Ortho-Design, Inc. | Common Stock, $0.0001 par value per share | 9.9% | 95,662,500 | 0% | Orin Hirschman | 31 Dec 2025 | ||
| PYPD | PolyPid Ltd. | Ordinary Shares, no par value | 9.8% | $7,853,852 | +$2,623,659 | 1,793,117 | +50% | Orin Hirschman | 31 Dec 2025 |
| TLPH | Talphera, Inc. | Common Stock, $0.001 par value | 9.8% | $5,127,652 | +$227,653 | 4,661,502 | +4.6% | Orin Hirschman | 31 Dec 2025 |
| RNXT | Renovorx, Inc. | Common Stock | 9.8% | $4,474,798 | +$1,833,453 | 4,430,493 | +69% | AIGH Capital Management LLC | 31 Mar 2026 |
| IPWR | Ideal Power Inc. | Common Stock, par value $0.001 per share | 9.8% | $3,126,177 | +$1,824,620 | 1,181,696 | +140% | Orin Hirschman | 31 Mar 2026 |
| BFRI | Biofrontera Inc. | Common Stock, $0.001 par value per share | 7.9% | $741,320 | +$24,824 | 915,210 | +3.5% | Orin Hirschman | 31 Dec 2025 |
| BDSX | Biodesix, Inc. | Common Stock, par value $0.001 per share | 7.7% | $5,156,630 | 758,328 | Orin Hirschman | 31 Mar 2026 | ||
| ELUT | Elutia Inc. | Common Stock | 7.6% | $2,073,173 | -$4,426 | 3,068,185 | -0.21% | Orin Hirschman | 31 Dec 2025 |
| IDN | Intellicheck, Inc | Common Stock | 7.5% | $10,605,571 | +$9,527,894 | 1,517,249 | +884% | Orin Hirschman | 31 Mar 2026 |
| GRCE | Grace Therapeutics, Inc. | Common Stock | 5.9% | $3,157,115 | -$1,444,764 | 907,217 | -31% | Orin Hirschman | 31 Dec 2025 |
| FENC | FENNEC PHARMACEUTICALS INC. | Common Shares, no par value | 5.7% | $12,186,826 | 1,981,501 | Orin Hirschman | 31 Mar 2026 | ||
| ABEO | ABEONA THERAPEUTICS INC. | Common Stock, $0.01 par value | 5.4% | $13,893,270 | 3,100,000 | Orin Hirschman | 31 Mar 2026 | ||
| COYA | Coya Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 5.3% | $6,427,392 | -$1,309,338 | 1,108,171 | -17% | Orin Hirschman | 31 Dec 2025 |
| CLRB | Cellectar Biosciences, Inc. | Common Stock, $0.00001 par value | 4.9% | $586,444 | 2,022,221 | Orin Hirschman | 31 Dec 2024 | ||
| KPRX | Kiora Pharmaceuticals, Inc. | Common Stock, $0.0001 par value per share | 4.9% | $380,178 | -$123,265 | 192,984 | -24% | Orin Hirschman | 31 Dec 2025 |
| ACST | Grace Therapeutics, Inc. | Common Stock | 4.9% | 814,000 | Orin Hirschman | 31 Mar 2026 | |||
| LPTH | Lightpath Technologies Inc | Common Stock | 4.8% | $17,061,268 | -$12,469,513 | 2,151,484 | -42% | Orin Hirschman | 17 Oct 2025 |
| INAB | IN8bio, Inc. | Common Stock, $0.0001 Par Value Per Share | 4.4% | $17,987 | -$725,036 | 149,895 | -98% | Orin Hirschman | 30 Jun 2025 |
| PSTV | Plus Therapeutics, Inc. | Common Stock | 3.9% | $410,778 | +$231,288 | 1,283,681 | +129% | Orin Hirschman | 30 Jun 2025 |
| PSNL | Personalis, Inc. | Common Stock | 3.8% | $27,205,633 | -$6,982,468 | 3,416,720 | -20% | Orin Hirschman | 31 Dec 2025 |
| VSTM | Verastem, Inc. | Common Stock, $0.0001 par value per share | 3.6% | $8,298,970 | -$2,960,715 | 2,003,179 | -26% | Orin Hirschman | 30 Jun 2025 |
| TELA | TELA Bio, Inc. | Common Stock | 3.6% | $1,331,344 | -$1,171,674 | 1,416,323 | -47% | Orin Hirschman | 31 Mar 2025 |
| THTX | Theratechnologies, Inc. | Common Stock | 3.4% | $4,914,679 | -$2,228,024 | 2,082,491 | -31% | Orin Hirschman | 30 Jun 2025 |
| ELVA | Electrovaya Inc. | Common Stock | 1.3% | $3,134,069 | -$11,679,864 | 532,100 | -79% | Orin Hirschman | 30 Sep 2025 |
| MYO | Myomo, Inc. | Common Stock, $0.0001 par value per share | 1.3% | 523,000 | -85% | Orin Hirschman | 30 Sep 2025 | ||
| BKTI | BK Technologies Corp | Common Stock | 0.8% | $2,434,057 | -$13,346,680 | 32,615 | -85% | Orin Hirschman | 31 Mar 2026 |
| PHGE | BIOMX INC. | Common Stock, $0.0001 Par Value Per Share | 0.1% | $9,926 | -$397,480 | 38,175 | -98% | Orin Hirschman | 31 Dec 2025 |
| SCPH | SCPHARMACEUTICALS INC. | Common Stock | 0% | $0 | -$23,817,272 | 0 | -100% | Orin Hirschman | 30 Sep 2025 |
| VELO | Velo3D, Inc. | Common Stock, par value $0.00001 per share | 0% | $0 | 0 | Orin Hirschman | 10 Oct 2025 | ||
| IMMX | Immix Biopharma, Inc | Common Stock | 0% | $0 | 0 | Orin Hirschman | 31 Dec 2024 | ||
| ARQ | Arq, Inc. | Common Stock, $0.001 par value | 0% | $0 | -$6,325,632 | 0 | -100% | Orin Hirschman | 31 Mar 2026 |
Schedules 13D/G Reported by Orin Hirschman:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.